It said a urine sample provided by the Aprilia
rider at the Malaysian Grand Prix on Nov. 3 had shown an
"adverse analytical finding of a non-specified substance under
Section 1.1.a) Exogenous Anabolic Androgenic Steroids."
Iannone, the winner of the 2016 Austrian Grand Prix, can request
the analysis of his B sample, and he can be present when it is
investigated.
The suspension puts Iannone's MotoGP future in doubt, with his
contract with Aprilia running until the end of the 2020 season.
Iannone, who joined the team last year, has struggled to match
team mate Aleix Espargaro for the majority of the 2019 season.
He finished with 43 points to Espargaro's 63, and his best
finish was sixth place at the Australian Grand Prix at Phillip
Island.
Iannone's positive test marks the first official case of a
potential doping offense in the grand prix paddock since 2012,
when Moto2 rider Anthony West tested positive for
methylhexanamine. West had his Moto2 results over an 18-month
period voided retrospectively.
(Reporting by Alan Baldwin in London and Hardik Vyas in
Bengaluru; Editing by Hugh Lawson)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|